Search Results

Alpha Omega's Sterile Disposable NeuroProbes for MER devices are intended to be used in neurosurgery for temporary stimulation of, or recording electrical signals of a small area in the brain.

Alpha Omega's sterile Disposable Cannulas for MER are intended for guiding the NeuroProbes in Neurosurgery for temporary stimulation of, or recording electrical signals of a small area in the brain.

Alpha Omega's Sterile Disposable Recording Cables for MER are intended to be used in neurosurgery for connecting NeuroProbes to recording and stimulation device.

Alpha Omega's Sterile Disposable NeuroProbes, Cannulas and Recording Cables for MER are indicated for assisting Neurosurgeons, in the operation room during functional neurosurgery, to aid in placement of depth electrodes.

Sterile Disposables for MER

This appears to be a 510(k) clearance letter from the FDA for a medical device. This type of document typically does not contain the detailed study results, acceptance criteria, or performance metrics that you are requesting.

The letter confirms that the device, "Sterile Disposables for MER" from Alpha Omega Engineering, Ltd., has been found "substantially equivalent" to legally marketed predicate devices. This means it has similar technological characteristics and is intended for the same use as a device already on the market, implying that it is as safe and effective.

To provide the information you asked for, I would need access to the actual 510(k) submission, which is often much more detailed than the clearance letter itself and may contain the studies and data you're looking for.

Based on the provided text, I can only state that none of the requested information (acceptance criteria, device performance, study details, sample sizes, ground truth information, MRMC study, standalone performance) is present.

Ask a specific question about this device

Alpha Omega NeuroProbes are intended to be used in neurosurgery for temporary stimulation of, or recording electrical signals of a small area in the brain.

Not Found

The provided text is a 510(k) Premarket Notification letter from the FDA to Alpha Omega Engineering, Ltd. regarding their device, the "NeuroProbe."

This document does not contain any information about acceptance criteria or a study proving the device meets acceptance criteria.

The 510(k) letter confirms that the FDA has reviewed the premarket notification and determined the device is substantially equivalent to legally marketed predicate devices. This means the device can be marketed, subject to general controls and potentially additional controls if classified as Class II or III.

Specifically, the document lacks:

• A table of acceptance criteria and reported device performance.
• Information about sample sizes for test or training sets.
• Details on data provenance.
• Information on experts used to establish ground truth or adjudication methods.
• Any mention of a multi-reader multi-case (MRMC) comparative effectiveness study or a standalone algorithm performance study.
• Information about the type of ground truth used or how it was established.

The document's purpose is to grant market clearance based on substantial equivalence, not to detail performance studies or acceptance criteria met by the device.

Ask a specific question about this device